TRACIE HARRIS: Open Payments
NPI 1720608961 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 32 payments from 14 companies in 2025. Trend: 2023 $726 · 2024 $1,357 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $146 |
| Novo Nordisk Inc | 6 | $134 |
| INTUITIVE SURGICAL, INC. | 1 | $127 |
| Astellas Pharma US Inc | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Aimmune Therapeutics, Inc. | 2 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $32 |
Products named: AIRSUPRA, Da Vinci Surgical System, Veozah, Ozempic, LEQVIO, ZENPEP, CAPLYTA, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
